{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T10:22:09Z","timestamp":1758363729276,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.yjmcc.2020.11.001","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T21:19:40Z","timestamp":1604956780000},"page":"44-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fibroblast shifts in the hypertensive heart: How single cell RNA-sequencing will accelerate advancements in anti-fibrotic therapies"],"prefix":"10.1016","volume":"151","author":[{"given":"Alexandra M.","family":"Garvin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taben M.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2020.11.001_bb0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.yjmcc.2020.03.005","article-title":"Visualization of cardiovascular development, physiology and disease at the single-cell level: opportunities and future challenges","volume":"142","author":"Yifan","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.11.001_bb0010","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCULATIONAHA.117.030742","article-title":"Single-cell sequencing of the healthy and diseased heart reveals cytoskeleton-associated protein 4 as a new modulator of fibroblasts activation","volume":"138","author":"Gladka","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2020.11.001_bb0015","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/CIRCULATIONAHA.119.045115","article-title":"High-resolution transcriptomic profiling of the heart during chronic stress reveals cellular drivers of cardiac fibrosis and hypertrophy","volume":"142","author":"McLellan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2020.11.001_bb0020","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43882","article-title":"Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury","volume":"8","author":"Farbehi","year":"2019","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.yjmcc.2020.11.001_bb0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00395-019-0715-4","article-title":"Fibroblast polarization over the myocardial infarction time continuum shifts roles from inflammation to angiogenesis","volume":"114","author":"Mouton","year":"2019","journal-title":"Basic Res. Cardiol."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.11.001_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.02.008","article-title":"Dynamic interstitial cell response during myocardial infarction predicts resilience to rupture in genetically diverse mice","volume":"30","author":"Forte","year":"2020","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.11.001_bb0035","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics—2020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2020.11.001_bb0040","doi-asserted-by":"crossref","first-page":"563657","DOI":"10.4061\/2011\/563657","article-title":"The impact of hypertension on patients with acute coronary syndromes","volume":"2011","author":"Picariello","year":"2011","journal-title":"Int. J. Hypertens."},{"issue":"8","key":"10.1016\/j.yjmcc.2020.11.001_bb0045","doi-asserted-by":"crossref","first-page":"H1346","DOI":"10.1152\/ajpheart.00615.2015","article-title":"Persistent change in cardiac fibroblast physiology after transient ACE inhibition","volume":"309","author":"D\u2019Souza","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2020.11.001_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.yjmcc.2015.11.027","article-title":"Persistent phenotypic shift in cardiac fibroblasts: impact of transient renin angiotensin system inhibition","volume":"93","author":"Hale","year":"2016","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282820303242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282820303242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:32:02Z","timestamp":1758313922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282820303242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":10,"alternative-id":["S0022282820303242"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2020.11.001","relation":{},"ISSN":["0022-2828"],"issn-type":[{"type":"print","value":"0022-2828"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast shifts in the hypertensive heart: How single cell RNA-sequencing will accelerate advancements in anti-fibrotic therapies","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2020.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}